Home News Company news...
July 15, 2026

Glymate x MEBO Selected for the 78th Emmy Awards Giving Suite

The Television Academy has officially announced the brand lineup for the 78th Emmy Awards Giving Suite, with Glymate x MEBO, MEBO’s innovative dietary supplement brand, selected among the featured brands for this exclusive backstage experience. The recognition marks another milestone in MEBO’s expanding presence within Hollywood’s premier award-season events. MEBO’s premium skincare brand MIAGE has also been featured in Emmy Awards gift programs on multiple occasions, becoming a recurring luxury skincare brand showcased during major entertainment events.

Produced by entertainment marketing firm Distinctive Assets, the 78th Emmy Awards Giving Suite is the only officially sanctioned Giving Suite associated with the Emmy Awards. The exclusive backstage experience invites Emmy presenters and nominees to select from a curated collection of premium products, while participating brands contribute to the philanthropic mission of the Television Academy Foundation, supporting initiatives that provide opportunities for emerging television talent, including internship programs, student awards, and television history preservation projects.

Selected alongside globally recognized brands including HydroJug, Motorola, and Pop Mart, Glymate x MEBO’s inclusion highlights growing international recognition of MEBO’s wellness innovation and brand philosophy.

The 78th Emmy Awards will air live from the Peacock Theater at L.A. LIVE in Los Angeles on September 14, 2026, on NBC and stream on Peacock. The selection of Glymate x MEBO for the Emmy Awards Giving Suite further strengthens MEBO’s global brand visibility and its engagement with international premium consumer markets.
 
Source: Television Academy Official Website
78th Emmy Awards Giving Suite
 

 

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.